China Pharmaceuticals and Healthcare Report Q1 2015

China Pharmaceuticals and Healthcare Report Q1 2015

Includes 3 FREE quarterly updates

BMI View:
Improvements in intellectual property protection, an ageing population and increasing access to healthcare will drive the robust growth of China's pharmaceutical market. This will attract foreign drug manufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegal practices.

Headline Expenditure Projections
- Pharmaceuticals: CNY532.4bn (USD86.6bn) in 2013 to CNY616.1bn (USD100.6bn) in 2014; +15.7% in local currency and +16.1% in US dollar terms.
- Healthcare: CNY3,230.8bn (USD525.4bn) in 2013 to CNY3,733.1bn (USD609.2bn) in 2014; +15.6% in local currency terms and +15.9% in US dollar terms. Forecast has been upgraded from Q414 due to upgraded growth in private health expenditure.
BMI Industry View ... 7
SWOT ... 9
Political 11
Economic .. 12
Business Environment .. 13
Industry Forecast .. 14
Pharmaceutical Market Forecast 14
Table: Pharmaceutical Sales, Historical Data And Forecasts (China 2010-2018) 15
Healthcare Market Forecast .. 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (China 2010-2018) . 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (China 2010-2018) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (China 2010-2018) . 20
Prescription Drug Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (China 2010-2018) 23
Patented Drug Market Forecast . 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (China 2010-2018) . 25
Generic Drug Market Forecast .. 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (China 2010-2018) 27
OTC Medicine Market Forecast . 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (China 2010-2018) . 30
Pharmaceutical Trade Forecast . 31
Table: Pharmaceutical Trade Data And Forecasts (China 2012-2018) . 32
Table: Pharmaceutical Trade Data And Forecasts local currency (China 2012-2018) . 33
Other Healthcare Data . 34
Key Risks To BMI's Forecast Scenario . 35
Macroeconomic Forecasts ... 37
Stimulus Effects Increasingly Short-Lived ... 38
Table: Economic Activity (China 2009-2018) 42
Industry Risk Reward Index . 43
Asia Pacific Risk/Reward Index .. 43
China Risk/Reward Index .. 49
Rewards .. 49
Risks ... 49
Market Overview ... 51
Industry Trends And Developments 52
Epidemiology ... 52
Table: Death Rate Of Major Diseases In Urban And Rural Areas (2012) . 55
Healthcare Sector . 56
Research And Development .. 66
Table: Selected List Of MNC With R&D Bases In China 67
Table: Selected List Of Collaboration In R&D Operations In China 74
Clinical Trials .. 76
Biotechnology Sector .. 80
Regulatory Development .. 87
Regulatory Regime 87
Table: Important China GMP Deadlines . 91
Intellectual Property Issues .. 93
Pricing Regime . 99
Reimbursement Regime . 109
Competitive Landscape .. 113
Pharmaceutical Industry ... 113
Table: Top 20 China / Hong Kong-Based Pharmaceutical Companies According To Market Capitalisation . 113
Pharmaceutical Wholesale . 114
Recent Developments 115
Traditional Chinese Medicine . 127
Company Profile .. 131
AstraZeneca 131
Bayer . 137
China Shijiazhuang Pharmaceutical Group 141
Eli Lilly .. 143
GlaxoSmithKline .. 147
North China Pharmaceutical Corporation .. 152
Novartis .. 155
Merck & Co . 161
Merck KGaA ... 166
Pfizer . 169
Roche . 173
Sanofi . 179
Shanghai Pharmaceutical ... 184
Sinopharm ... 188
Demographic Forecast ... 193
Table: Population Headline Indicators (China 1990-2025) . 194
Table: Key Population Ratios (China 1990-2025) 194
Table: Urban/Rural Population & Life Expectancy (China 1990-2025) 195
Table: Population By Age Group (China 1990-2025) . 195
Table: Population By Age Group % (China 1990-2025) 196
Glossary ... 198
Methodology 200
Pharmaceutical Expenditure Forecast Model 200
Healthcare Expenditure Forecast Model ... 200
Notes On Methodology .. 201
Risk/Reward Index Methodology . 202
Index Overview ... 203
Table: Pharmaceutical Risk/Reward Index Indicators 203
Indicator Weightings 204
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.